SARS News and Research

RSS

EIS Conference highlights CDC’s disease detectives’ outbreak investigations, innovative analyses on public health

CDC will hold its annual Epidemic Intelligence Service Conference May 2-5, 2022, via a virtual platform that is free and open to the public.

3 May 2022

Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with two repatriation flights from India to Australia

Researchers conducted epidemiologic and genomic studies to investigate in-flight SARS-CoV-2 infection associated with repatriation flights from India to Australia in April 2021.

3 May 2022

Study uncovers blood clotting and immune protein pathways impacted in children with severe COVID-19

Researchers have discovered the blood clotting and immune protein pathways that are activated in severe cases of COVID-19 in children, paving the way for earlier diagnosis and more targeted treatments.

3 May 2022

Long COVID is characterized SARS-CoV-2 antigen persistence in the gut mucosa

A new study published in the journal Gastroenterology used upper and lower gastrointestinal endoscopy to assess whether gut antigen persistence leads to post-acute COVID-19 in patients with or without post-acute COVID-19 symptoms.

3 May 2022

Prior SARS-CoV-2 infection provides substantial and sustained protection from Omicron hospitalization

A population-level study conducted on residents of the Quebec province, Canada, has demonstrated that prior infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces robust and long-lasting protection against omicron re-infection and hospitalization. The level of protection further increases with coronavirus disease 2019 (COVID-19) vaccination.

3 May 2022

Understanding how the COVID pandemic impacts childhood autism and neurodevelopmental disorders

A study posted to the medRxiv* preprint server assessed the effects and outcomes of the COVID-19 pandemic on children suffering from neurodevelopmental disorders, with an emphasis on patients of autism spectrum disorder (ASD).

3 May 2022

Schools' role in the spread of SARS-CoV-2

The Omicron wave of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)––the causative pathogen for coronavirus disease 2019 (COVID-19) and the current pandemic––led to rampant transmissions in schools. Therefore, the school-based viral transmission must be curtailed to reduce viral evolution and maintain children's in-person education.

2 May 2022

Tracking BA.2.12.1 🦠 by partial ORF1ab gene 🧬 target failure (pOGTF)

Scientists from the United States have recently identified a novel approach to rapidly and accurately detect the omicron BA.2.12.1 sub-lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in clinical samples.

2 May 2022

P681 mutations in SARS-CoV-2 spike protein determine fusogenicity

Researchers evaluated the importance of the P681 residue within the furin cleavage site of SARS-CoV-2 spike protein in determining the fusogenicity and syncytia formation ability of SARS-CoV-2 strains.

2 May 2022

Exploring changes in non-COVID-19 hospitalization rates before and during COVID-19

Researchers assessed the trends in non-COVID-19 hospitalizations before and during the COVID-19 pandemic in the United States between 2017 and 2021.

2 May 2022

Estimating COVID-19 case prevalence in New York City

Researchers estimated the prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in New York City (NYC).

2 May 2022

Prevalence of low-molecular-weight heparin prescription in pregnant women according to level of venous thromboembolic disease risk

The present study was carried out to determine how often LMWH was prescribed in pregnancy, the risk classification of such women based on the ETV-OBS risk calculator, and how the risk varied with the occurrence of SARS-CoV-2 infection.

2 May 2022

Fourth dose of COVID-19 vaccine reduced death among hospitalized patients during Omicron wave in Israel

Researchers investigated the effect of a fourth dose of the coronavirus disease 2019 (COVID-19) vaccine in patients with severe disease symptoms.

2 May 2022

Study estimates the elevated risks of COVID-19 breakthrough infection and hospitalization in fully vaccinated individuals with comorbidities

The current study aimed to understand both the risk of breakthrough infection and severe outcomes in this population.

2 May 2022

SARS News and Research

EIS Conference highlights CDC’s disease detectives’ outbreak investigations, innovative analyses on public health

Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with two repatriation flights from India to Australia

Study uncovers blood clotting and immune protein pathways impacted in children with severe COVID-19

Long COVID is characterized SARS-CoV-2 antigen persistence in the gut mucosa

Prior SARS-CoV-2 infection provides substantial and sustained protection from Omicron hospitalization

Understanding how the COVID pandemic impacts childhood autism and neurodevelopmental disorders

Schools' role in the spread of SARS-CoV-2

Tracking BA.2.12.1 🦠 by partial ORF1ab gene 🧬 target failure (pOGTF)

P681 mutations in SARS-CoV-2 spike protein determine fusogenicity

Exploring changes in non-COVID-19 hospitalization rates before and during COVID-19

Estimating COVID-19 case prevalence in New York City

Prevalence of low-molecular-weight heparin prescription in pregnant women according to level of venous thromboembolic disease risk

Fourth dose of COVID-19 vaccine reduced death among hospitalized patients during Omicron wave in Israel

Study estimates the elevated risks of COVID-19 breakthrough infection and hospitalization in fully vaccinated individuals with comorbidities

Higher contact among vaccinated people may negatively influence vaccine effectiveness

Neutralizing antibodies produced following COVID-19 BNT162b2 vaccine found to activate complement cascade

Longitudinal and proteome-wide analysis of antibodies in COVID-19 patients using a SARS-CoV-2 proteome microarray

The generation of SARS-CoV-2 virus-like particles in insect cells

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

SARS-CoV-2-specific T cells are broader after vaccination than after infection

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News